If You Bought or
Provided Reimbursement
for the Dry-Eye Disease Drug
Restasis®

You Could Be Included In a
Class Action Lawsuit

Para conseguir una notificación en español,
llame a 1-877-868-6810

  • You could be affected by a class-action lawsuit against Allergan, Inc. over prices of the dry-eye disease drug Restasis.
  • The Court approved the lawsuit as a class action on behalf of a “class,” or group of people, that could include you..
  • The parties have reached an agreement to resolve the lawsuit and are preparing to present the proposed settlement to the Court, which they hope to do by July 2021. The settlement is not final and is subject to Court approval..
  • The deadline to exclude yourself from the class action is currently suspended.
  • You do not have to do anything right now to protect your rights.
  • If the Court preliminarily approves the settlement, the Court will authorize the distribution to the Class of a notice summarizing the settlement, describing the process for excluding yourself from or responding to or objecting to the settlement, and explaining the procedures for final approval and distribution of funds.
  • Please check this website regularly for updates.




This is a class action lawsuit. The Class includes: Consumers and third-party payors (entities such as employers or insurers with self-funded prescription drug plans). Specifcally, the class includes:

1. Consumers: all persons who, from May 1, 2015 to the present, purchased Restasis in a pharmacy for their own use, or received Restasis by mail-order prescription for their own use, in any of the following states: Arizona, Arkansas,* California, Colorado, the District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Maine, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, Rhode Island, South Dakota, Tennessee, Utah, Vermont, West Virginia, and Wisconsin.

2. Third-party payors all entities that from May 1, 2015 to the present, paid for and/or provided reimbursement for some or all of the purchase price for Restasis for use by their members, employees, insureds, participants, or beneficiaries, where such persons purchased the drug in a pharmacy or received Restasis by mail-order prescription, in the following states: Arizona, Arkansas,* California, Colorado, the District of Columbia, Florida, Hawaii, Illinois, Iowa, Kansas, Michigan, Minnesota, Mississippi, Nebraska, Nevada, New Hampshire, New Mexico, New York, North Carolina, North Dakota, Oregon, Rhode Island, South Dakota, Tennessee, Utah, West Virginia, and Wisconsin.

* Arkansas purchases, payments, and reimbursements for Restasis
must have occurred between May 1, 2015 and July 31, 2017.



REMEMBER TO CHECK THIS WEBSITE REGULARLY FOR UPDATES